ClinicalTrials.gg
RecruitingNCT06675097FLATQUALUpdated Aug 10, 2026

Assessment of the Impact of Intestinal Gas Emission Quality on the Postoperative Course After Abdominal Surgery

An observational study in Postoperative Complication and Recovery, Physiological, sponsored by University Hospital, Angers. Recruiting at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-10.

Sponsored by University Hospital, Angers · Observational

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 64 studies in Postoperative Complications with a site in France — 7 open to participants now, 8 under way, 2 of them phase 3. Postoperative Complications · France.

Planned enrollment
19th of 32
200 · median 260
Started
2025
with 6 others
Observational
32 of 64
3 open now
Registered
57th of 64
by date
Lead sponsor
4 of 64
University Hospital, Angers

Among the 64 studies in Postoperative Complications with a site in France, this one is the 19th largest by planned enrollment of the 32 observational ones that give a count, is one of 7 that started in 2025, is one of 32 observational ones, and was the 57th registered.

Postoperative Complications

1,335 studies on the registry are indexed under Postoperative Complications; 309 are open to participants now.

Browse Postoperative Complications studies →

Open to participants now

7 of the 64 studies in Postoperative Complications with a site in France are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 200 Postoperative Complications studies recruiting now, 125 (63%) set no upper age limit and 32 (16%) stop at 75 or younger; 24 take children under 18; 25 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 64 studies in Postoperative Complications with a site in France, or all of them as a file.
02

Study summary

The recovery of transit after surgery is an important parameter in postoperative evaluation. It generally reflects simple postoperative outcomes and allows the patient to return home.

The quality of gas recovery after surgery has not been studied to our knowledge, but it is not uncommon for an operated patient to emit some gas considered as a recovery of transit when it is ultimately a false transit preceding a postoperative ileus. Furthermore, intestinal gases and their composition reflect the intestinal microbiota. This microbiota has been shown to be predictive of the appearance of an operative complication. As the analysis of this microbiota cannot be carried out routinely, it is important to be able to use a reflection of this microbiota in routine practice and to correlate it with the surgical outcomes. Intestinal gas therefore seems to be the tool of choice.

The main objective is to evaluate the association between the appearance of an operative complication and the resumption of gas transit qualified according to its quantity and quality.

The secondary objectives are to compare the quantity and quality of gases pre- and post-operatively and to define a predictive score for surgical complications, based on the number and quality of post-surgical gases.

Data regarding gas transit are collected by the patient in a questionnaire the two days before the surgery and until the patient leaves hospital (or until day 15 post-operative if the patient is still hospitalized).

Data regarding possible complications ((defined according to Dindo-Clavien as any deviation from the expected postoperative outcomes within 90 days following surgery) are collected throughout the hospital stay (day 0 : surgery to day 15 post-operatively), during the post-operative consultation (day 30) and during a telephone call to the patient (day 90).

The expected results are to highlight a correlation between the quality/quantity of gases and post-operative outcomes. A predictive score for complications could then be proposed and validated during this study.

03

Conditions studied

  • Postoperative Complication
  • Recovery, Physiological

Keywords

  • transit
  • surgery
  • abdomen
  • stool
  • gas
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The patients will be included in the hospital they will be operated on

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients ≥18 years old
  • Indication for open or laparoscopic abdominal surgery
  • Whose expected length of stay is ≥ 2 days

Non Inclusion Criteria:

  • Patients requiring a stomy on the initial surgery
  • Emergency surgery
  • Patient not knowing how to read or write
  • Poor understanding of the French language
  • Person deprived of liberty by judicial or administrative decision
  • Person subject to psychiatric care under duress
  • Person subject to a legal protection measure
  • Person unable to express consent
  • Person objecting to participating in research

Exclusion criteria

Exclusion Criteria:

-Immediate post-operative intensive care with patient intubation

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. To evaluate the association between the appearance of an operative complication and the resumption of gas transit qualified according to its quantity and quality.

    Operative complication is defined according to Dindo-Clavien as any deviation from the expected postoperative outcomes within 90 days following surgery. Complications are then classified according to the Dindo-Clavien classification from 1 (simplest) to 5 (death).

    Time frame: From Day 0 (surgery) to the 90 post-operative days +/- 15 days.

  2. To evaluate the association between the appearance of an operative complication and the resumption of gas transit qualified according to its quantity and quality.

    The resumption of gas transit will be defined as the emission of gas for at least 2 days in a row. • The quantity corresponds to the number / 24 hours of gas

    Time frame: The 2 days before surgery and up to 15 days post-operative if the patient is still hospitalized.From Day 0 (surgery) to the 90 post-operative days +/- 15 days.

  3. To evaluate the association between the appearance of an operative complication and the resumption of gas transit qualified according to its quantity and quality.

    The resumption of gas transit will be defined as the emission of gas for at least 2 days in a row. • The quality is defined by: * Single or multiple over the same time * Noisy or soundless * Dry or wet (no stools but mucus or transparent liquids) * Accompanied by stools * Non-odorous, slightly odorous, very smelly * Painful before the show * Relief after emission

    Time frame: The 2 days before surgery and up to 15 days post-operative if the patient is still hospitalized.From Day 0 (surgery) to the 90 post-operative days +/- 15 days

Secondary outcomes

  1. to compare the quantity of gas pre- and post-operative

    • gas quantity corresponds to number/24 H of gas (data are daily collected by the patient in a questionnaire)

    Time frame: The 2 days before surgery and up to 15 days post-operative if the patient is still hospitalized

  2. to compare the quantity of stools pre- and post-operative

    • Stoll quantity corresponds to number/24 H of stool (data are daily collected by the patient in a questionnaire)

    Time frame: The 2 days before surgery and up to 15 days post-operative if the patient is still hospitalized

  3. to compare the quality of gases pre- and post-operative

    • Gas quality is defined by : * Single or multiple over the same time * Noisy or soundless * Dry or wet (no stools but mucus or transparent liquids) * Accompanied by stools * Non-odorous, slightly odorous, very smelly * Painful before the show * Relief after emission .Data from gas are daily collected by the patient in a questionnaire.

    Time frame: The 2 days before surgery and up to 15 days post-operative if the patient is still hospitalized

  4. to compare the quality of stool pre- and post-operative

    •stool quality is defined by the Bristol scale (type 1: separate hard lumps (severe constipation); type 2: lumpy and sausage-like (mild constipation); type 3: sausage shape with cracks (normal); type 5: soft blobs with clear-cut edges (lacking fiber); type 6: mushy consistency with ragged edges (mild diarrhea); type 7: liquid consistency with no solid pieces (severe diarrhea). .data are daily collected by the patient in a questionnaire

    Time frame: The 2 days before surgery and up to 15 days post-operative if the patient is still hospitalized

07

Study locations

2 of 2 sites recruiting
  • University Hospital of Nantes, CIC Institut des Maladies de l'appareil digestif, CHU Nantes, 1 place Alexis Ricordeau 44093 Nantes cedex 01
    Nantes, Loire Atlantique 44093, France
    Recruiting
  • Angers Hospital (visceral surgery department)
    Angers, 49933, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Jan 2027, 24 months after the start.

Of 276 non-industry observational studies under Postoperative Complications, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's planned 24 months is close to that.

Counting every sponsor, half of 281 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 4, 2024
First posted
Nov 5, 2024
StartActual
Jan 31, 2025
Primary completionEst.
Jan 31, 2027
CompletionEst.
Apr 2027
Last update
Aug 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06675097
Responsible party
Sponsor
First posted
Nov 5, 2024
Start date
Jan 31, 2025
Primary completion
Jan 31, 2027 (estimated)
Completion
Apr 2027 (estimated)
Last update
Aug 10, 2026

Study contacts

Aurelien VENARA, MD, PhD
Contact
AuVenara@chu-angers.fr
33 2 41 35 36 18
UH Angers DRCI
Contact
DRCI-Promotion-Interne@chu-angers.fr
33 2 41 35 54 96

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion